Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 2
2017 1
2021 3
2022 2
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R, Katsarava Z, MaassenVanDenBrink A, Martelletti P, Mitsikostas DD, Ornello R, Reuter U, Sanchez-Del-Rio M, Sinclair AJ, Terwindt G, Uluduz D, Versijpt J, Lampl C. Sacco S, et al. Among authors: deligianni ci. J Headache Pain. 2022 Jun 11;23(1):67. doi: 10.1186/s10194-022-01431-x. J Headache Pain. 2022. PMID: 35690723 Free PMC article. Review.
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
Raffaelli B, García-Azorín D, Boucherie DM, Amin FM, Deligianni CI, Gil-Gouveia R, Kirsh S, Lampl C, Sacco S, Uluduz D, Versijpt J, MaassenVanDenBrink A, Zeraatkar D, Sanchez-Del-Rio M, Reuter U. Raffaelli B, et al. Among authors: deligianni ci. J Headache Pain. 2023 Oct 10;24(1):134. doi: 10.1186/s10194-023-01671-5. J Headache Pain. 2023. PMID: 37814223 Free PMC article. Review.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
Lampl C, Versijpt J, Amin FM, Deligianni CI, Gil-Gouveia R, Jassal T, MaassenVanDenBrink A, Ornello R, Paungarttner J, Sanchez-Del-Rio M, Reuter U, Uluduz D, de Vries T, Zeraatkar D, Sacco S. Lampl C, et al. Among authors: deligianni ci. J Headache Pain. 2023 Apr 11;24(1):39. doi: 10.1186/s10194-023-01573-6. J Headache Pain. 2023. PMID: 37038134 Free PMC article.
Depression in headaches: chronification.
Deligianni CI, Vikelis M, Mitsikostas DD. Deligianni CI, et al. Curr Opin Neurol. 2012 Jun;25(3):277-83. doi: 10.1097/WCO.0b013e328352c416. Curr Opin Neurol. 2012. PMID: 22547099 Review.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
Deligianni CI, Sacco S, Ekizoglu E, Uluduz D, Gil-Gouveia R, MaassenVanDenBrink A, Ornello R, Sanchez-Del-Rio M, Reuter U, Versijpt J, de Vries T, Hussain M, Zeraatkar D, Lampl C. Deligianni CI, et al. J Headache Pain. 2023 Sep 19;24(1):128. doi: 10.1186/s10194-023-01657-3. J Headache Pain. 2023. PMID: 37723437 Free PMC article. Review.
Visual snow: A systematic review and a case series.
Sampatakakis SN, Lymperopoulos L, Mavridis T, Karagiorgis G, Papadopoulos C, Deligianni CI, Mitsikostas DD. Sampatakakis SN, et al. Among authors: deligianni ci. Cephalalgia. 2022 Nov;42(13):1409-1419. doi: 10.1177/03331024221118917. Epub 2022 Aug 9. Cephalalgia. 2022. PMID: 35945691
18 results